NCT02859623View on ClinicalTrials.gov

Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN)

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2015

Conditions
Blastic Plasmacytoid Dendritic Cell NeoplasmHematological Malignancies
All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT02859623 - Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN) | Biotech Hunter | Biotech Hunter